age-related%20macular%20degeneration
AGE-RELATED MACULAR DEGENERATION
Age-related macular degeneration is a common, chronic, progressive, degenerative disease that causes central loss of vision due to abnormalities that occurs in the pigment, neural and vascular layers of the macula.
The macular disorder may have one or more of the following:
- Formation of drusen which are localized deposits of extracellular material usually concentrated in the macula
- Abnormalities in the retinal pigment epithelium (eg hypopigmentation or hyperpigmentation)
- Retinal pigment epithelium and choriocapillaris geographic atrophy
- Neovascular (exudative) maculopathy
Decreased central vision and distortion of seeing straight lines are the most common symptoms.
  1. Rosenfeld P, Martidis A, Tennant M. Age-related macular degeneration. In: Yanoff M, Duker JS, et al. Ophthalmology. 3rd ed. Maryland Heights, MO: Mosby, Elsevier; 2009
  2. International Council of Ophthalmology. Age-related macular degeneration (management recommendations). http://www.icoph.org/downloads/ICOARMDMa.pdf. Apr 2007
  3. Arroyo J. Age-related macular degeneration: epidemiology, etiology and diagnosis. UpToDate. http://www.uptodate.com/contents/age-related-macular-degeneration-clinical-presentation-etiology-and-diagnosis?source=search_result&search=Arroyo+J%09%22+Age-related+macular+degeneration%3A+epidemiology%2C+etiology++and++diagnosis%22&selectedTitle=1~53. Jul 2012. Accessed 15 Aug 2012
  4. The Royal College of Ophthalmologists. Age-related macular degeneration guidelines for management. http://www.rcophth.ac.uk/core/core_picker/download.asp?id=1851&filetitle=Age%2DRelated+Macular+Degeneration%3A+Guidelines+for+Management+2013. Feb 2009
  5. Arroyo J. Age-related macular degeneration: treatment and prevention. UpToDate. http://www.uptodate.com/contents/age-related-macular-degeneration-treatment-and-prevention?source=search_result&search=Arroyo+J%09%22+Age-related+macular+degeneration%3A+epidemiology%2C+etiology++and++diagnosis%22&selectedTitle=2~53. Jul 2012. Accessed 15 Aug 2012
  6. American Optometric Association. Optometric clinical practice guideline. Care of the adult patient with age-related macular degeneration. http://www.aoa.org/documents/CPG-6.pdf. 2004
  7. American Academy of Ophthalmology Retina Panel. Preferred practice pattern guidelines. Age-related macular degeneration. San Francisco, CA: American Academy of Ophthalmology. American Academy of Ophthalmology. http://www.google.com.ph/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CCoQFjAA&url=http%3A%2F%2Fone.aao.org%2Fasset.axd%3Fid%3Db1f95ead-7fd4-49e7-bcc9-b12249916069&ei=xIyeUuKWBYa8kgWkqIHYBg&usg=AFQjCNE8T9-ddaNh2A1c3BCjguF08ZdcQw&sig2=GmaAYwa8Ea5mj9S607b3. 2008
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 2 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 3 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.